Latest filing published 10 Dec 2023 for ODI Pharma AB (publ), €711k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -39.4%Entry SEK 9.76 · Close at T+365 SEK 5.91
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Derek Simmross: trading record in brief
Derek Simmross discloses dealings in ODI Pharma AB (publ) to Finansinspektionen. Between 16 January 2020 and 6 December 2023, the trades on record add up to 3 filings.
In open-market terms, that means 1 purchase worth €112k on one side and 1 sale worth €146k on the other. Sales outweigh purchases by €34k. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 10 December 2023, reports a transaction of €711k in ODI Pharma AB (publ). The most recent open-market purchase was published on 17 January 2020, 2,486 days ago. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Derek Simmross
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,300,000 shares@ SEK 3.5073.3% of flowAktieISIN SE0013409760FI:csv-c81f11c00a854c125d03
- 128,532 shares@ SEK 12.006556.6% of flowAktieISIN SE0013409760FI:csv-de893a484fb05a7fae5b
- 128,532 shares@ SEK 9.2043.4% of flowAktieISIN SE0013409760FI:csv-69904987c1dc88c6f8b1Canonical exit: 15 Apr 2020 (T+90)
3 of 3 declarations